Objective: Early age at menopause is associated with increased risk of cardiovascular disease, stroke, osteoporosis, and all-cause mortality. Cigarette smoke exposure in adulthood is an established risk factor for earlier age at natural menopause and may be related to age at the menopausal transition. Using data from two US birth cohorts, we examined the association between smoke exposure at various stages of the life course (prenatal exposure, childhood exposure to parental smoking, and adult smoke exposure) and menopause status in 1,001 women aged 39 to 49 years at follow-up.
A lthough the menopausal transition and menopause are stages of life experienced by all women, the age at which women experience these changes may influence their health risks. Natural menopause is defined as at least 12 months of amenorrhea that is not attributable to surgical operation, chemotherapy, or any other known cause; the menopausal transition is a biologic phase that precedes natural menopause. Earlier age at natural menopause is associated with an increased risk of certain diseases, including osteoporosis, some types of cancer, stroke, and heart disease; studies have even reported an increase in all-cause mortality associated with earlier menopause. [1] [2] [3] [4] For this reason, it is important to identify modifiable risk factors that can increase a woman's risk of experiencing early menopausal transition or menopause. Current cigarette smoking in adulthood is an established risk factor for earlier age at natural menopause. [5] [6] [7] [8] Current smoking has also been associated with earlier onset of the menopausal transition. [9] [10] [11] [12] Menopause occurs when the ovarian follicle pool falls below some critical threshold. [13] [14] [15] One possible explanation for the association between current smoking and earlier age at menopause is that smoking by products decrease the quantity or quality of ovarian follicles. [16] [17] [18] Smoking is also associated with changes in reproductive hormone levels during the reproductive years and in the years preceding menopause. [19] [20] [21] These associations may reflect alterations in the patterns of follicle development, which could manifest as changes in the levels of follicle-stimulating hormone (FSH) or other hormones, or may reflect a primary effect on the pituitary.
As ovarian follicles are only formed during fetal development, it is possible that smoke exposure during the intrauterine period may also affect the follicle pool and influence menopausal timing. If prenatal smoke exposure accelerates menopause, it may do so either by suppressing the formation of follicles or by damaging them. Evidence from a Danish study by Lutterodt et al 22 suggests that prenatal smoke exposure may damage somatic cells in the developing ovary.
Few studies have examined the association between prenatal smoke exposure and age at menopause. A prospective study that used data from the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project reported a modest association between prenatal smoke exposure and earlier age at menopause (hazard ratio, 1.2; 95% CI, 1.0-1.43). 23 Two other studies that relied on daughters' report of maternal smoking did not observe associations: one was a cross-sectional study of data from the US Sister Study, 24 and the other reported no association between prenatal smoke exposure and indicators of ovarian age, including antral follicle count and levels of FSH, inhibin B, and estradiol in women aged 22 to 49 years. 21 We examined life course smoke exposure and early menopausal transition and natural menopause, using data from two birth cohorts in which information on smoking was collected prospectively from the mothers themselves during their pregnancies and the daughters were followed up more than four decades later.
METHODS

Study participants
We used prospectively collected data from the Early Determinants of Mammographic Density (EDMD) Study (for details, see Terry et al 25 and Susser et al 26 ) to examine the association between smoke exposure throughout the life course and early menopausal transition and natural menopause. In brief, the EDMD Study is a follow-up study of women whose mothers enrolled in one of two birth cohorts: the New England Collaborative Perinatal Project (CPP) or the California Child Health and Development Study (CHDS). [27] [28] [29] The EDMD Study used baseline data obtained from the mothers during their pregnancies (1959) (1960) (1961) (1962) (1963) (1964) (1965) (1966) (1967) . Because the protocols of the CPP and CHDS were very similar, we were able to analyze both samples in the EDMD Study. In 2006-2008, when the daughters (referred to as participants throughout this article) were aged 39 to 49 years, we conducted an adult follow-up study. We used the following criteria to determine eligibility for inclusion in the adult follow-up study: singleton birth, recorded birthweight and birthlength, recorded childhood weight and height measurements, availability of third trimester serum, and female sex.
In the CPP, 1,775 daughters met the eligibility criteria. We had resources to contact a little more than half of the women who were eligible, and we did so by sampling randomly from the eligible pool of 1,775 daughters (n ¼ 1,090; 61%). Of these, we were able to locate 644 (59%); 567 (88%) participated. In the CHDS, 1,481 daughters met the eligibility criteria. We had resources to contact 835 (56%) and therefore sampled randomly from the eligible pool. Of these, we located 675 (81%); 567 (84%) participated. We used the last known address of the daughter or her mother to locate the potential participant. Routine surveillance methods used by the CHDS are described elsewhere. 25, 26 Participants in the adult followup study did not differ from eligible nonparticipants with respect to the baseline variables of interest, including birthweight, prenatal smoke exposure, and maternal age (data not shown).
Of the 1,134 women who were interviewed for the EDMD Study, our analyses excluded 133 women who had experienced surgical menopause, who had experienced menopause induced by chemotherapy or radiation, or whose menopause status could not be determined with certainty because of hormone therapy (HT) or incomplete medical history.
Data collection Mother data
All prenatal and early life data including maternal smoking, were collected based on uniform protocols for the CPP and CHDS, using interview instruments and clinical measurements during the mother's pregnancy. Covariates included the mother's education at the participant's birth, family income at birth, birthweight, and birthlength.
Participant data
Trained interviewers interviewed adult participants by telephone using a standard protocol. The interview included information on the participant's smoking status and smoking history, smoke exposure during childhood, menstrual status, parity, hormone use, weight, height, education, and annual family income.
Smoke exposure variables Prenatal smoke exposure
We defined prenatal smoke exposure based on the pregnant mother's report on whether she smoked. Mother's report had a very high correlation with cotinine measures in a subset of mothers tested. 30 We carried out a secondary analysis in which we defined prenatal exposure as the reported number of cigarettes smoked per day during pregnancy.
Childhood household smoke exposure
We asked the participants whether anyone (mother/stepmother, father/stepfather, or someone else) who lived with them at any time in their first 18 years of life had smoked and, if so, for how many years they were exposed to one or more household members' smoke. We classified childhood smoke exposure as follows: dichotomously (ever vs never), by number of smokers with whom the participant lived (none, one, two or more), and by duration of exposure (>10 y, 10 y). We used the latter two measures as proxies for degree of exposure.
Adult active smoking
We asked participants if they had ever smoked in the past and if they currently smoked. We also asked ever smokers how old they were when they started and stopped smoking and LIFE COURSE EXPOSURE TO SMOKE AND MENOPAUSE the average number of cigarettes they smoked per day. We classified participants as nonsmokers if they had never smoked, as former smokers if they had smoked at least one cigarette per day for at least 1 month but were not smoking at the time of interview, and as current smokers if they smoked at least one cigarette per day at the time of interview. We did not collect data on passive smoke exposure in adulthood.
Menopause status Premenopause
We classified participants as premenopausal if they were menstruating, had not gone 60 consecutive days without a period during the 12 months preceding the interview, or were pregnant at the time of the interview.
Menopausal transition
We classified participants as being in the menopausal transition if, in the 12 months before the interview, they had (i) at least one period and (ii) at least one episode of amenorrhea lasting 60 or more days in the absence of pregnancy or lactation. This definition accords with those set out by the Stages of Reproductive Aging Workshop 31 and ReSTAGE Collaboration. 32 Because participants who have experienced natural menopause have, by definition, experienced 60 or more days of amenorrhea during the 12 months preceding the interview, we report odds ratios (ORs) for associations with the timing of the menopausal transition, including participants who have experienced natural menopause. We also report ORs for women in the menopausal transition, excluding women who have reached natural menopause.
Natural menopause
We classified as having experienced natural menopause participants whose final menstrual period had occurred more than 12 months before the interview and who did not report surgical operation, radiation therapy, or chemotherapy as reason for cessation of their periods.
Hormone therapy
We excluded from analysis participants who were using hormone therapy (HT) at the time of interview and who were premenopausal or in the menopausal transition. We also excluded from analysis participants in the premenopausal category or in the menopausal transition who were past HT users and had not experienced an observed unmedicated period after stopping HT. Women who had experienced a final menstrual period at least 12 months before starting HT were classified as menopausal.
Statistical analysis Analytic approach
We used logistic regression analysis to estimate ORs and 95% CIs relating the various measures of smoke exposure to menopause status. All models included age at the time of interview and study site. Thus, ORs are interpreted as the odds of having earlier menopause (or being in the menopausal transition) given exposure status. Because 499 of the participants in this sample were sisters, we used generalized estimating equation logistic regression analysis to allow proper estimation of standard errors. For each smoke exposure construct (prenatal, childhood, and adult), we examined associations with menopause status in three separate analyses that compared the following: (i) participants who had reached natural menopause versus premenopausal women; (ii) participants who had experienced the menopausal transition but were not yet menopausal versus premenopausal women; and (iii) participants who had experienced the menopausal transition (including those who had reached menopause) versus premenopausal women. We refer to the last category as the ''combined category'' throughout this article. Initially, we examined each type of smoke exposure separately (prenatal, passive childhood, and adult smoking). In the final model, all three types of smoke exposure were adjusted for simultaneously.
Adjusting for age, site, and other confounders
We included age at interview (as a continuous variable) and study site (New England CPP or California CHDS) in all models. We examined the following covariates: birthweight, maternal education at birth, family income at birth, participant's adult body mass index, oral contraceptive use, parity, level of education, and annual family income at the time of interview. We included covariates in the final analytic model if their inclusion or exclusion produced a 10% or higher change in the regression coefficient relating exposure status to menopause status. We also examined interactions between smoke exposure at three stages: prenatal smoke exposure, passive childhood smoke exposure, and adult smoke exposure. The interactions were assessed by evaluating the significance of the cross-product term created by multiplying smoke exposure at different life periods.
We had incomplete smoke exposure data for four participants and missing data on prenatal smoke exposure for 29 participants. To examine whether this small proportion of missing data had influenced the results significantly, we conducted sensitivity analyses in which we modeled the association between prenatal smoke exposure and menopausal outcomes under different assumptions for the missing data. The age-adjusted and site-adjusted ORs did not vary appreciably under all modeled circumstances.
RESULTS
The final analytic sample included 1,001 women, of whom 499 were siblings. The mean (SD) age at interview was 43.6 (1.87) years. A total of 773 (77.2%) women were premenopausal, 190 (19.0%) women were in the menopausal transition, and 38 (3.8%) women had reached natural menopause. Approximately 41% of all participants had been exposed to prenatal smoke, and 73% had been exposed to household smoke during childhood. About 51% of all participants had never smoked; 32% were former smokers, and 16% were current smokers. Birthweight, maternal education at registration, prenatal smoke exposure, adult smoking status, annual household income, education, body mass index, and age at interview were associated with menopause status. Table 1 shows relevant characteristics of the participants.
Prenatal smoke exposure
The proportion of participants reaching early natural menopause was higher among participants with prenatal smoke exposure than among those without exposure. Adjusting for age and site, the OR relating prenatal smoke exposure to natural menopause was 2.0 (95% CI, 1.0-4.1; Table 2 ). Adjustment for maternal education at birth decreased the OR to 1.7 (95% CI, 0.8-3.3). Further adjustment for adult smoking, which is associated with earlier age at menopause, did not change the association appreciably. The association of prenatal smoke exposure with the odds of menopause did not vary with the number of cigarettes the mother smoked ( Table  3 ). The number of cigarettes the mother smoked during pregnancy was not associated with experiencing the menopausal transition (combined category, including women who experienced menopause) in the age-adjusted and site-adjusted models. Potential confounders that did not change the estimates appreciably were not included in the final models (birthweight, family income at birth, oral contraceptive use, participant's parity, level of education, and annual family income at the time of interview).
Childhood household smoke exposure Passive childhood smoke exposure was not associated with experiencing natural menopause or the menopausal transition (combined category) in this cohort (Table 4 ).
Adult smoking
The odds of women experiencing early natural menopause was higher among current smokers than among those who had never smoked (OR, 2.6; 95% CI, 1.0-6.7; Table 2 ). The odds of women experiencing the menopausal transition (combined category) was also higher among current smokers than among those who had never smoked (OR, 1.8; 95% CI, 1.2-2.7).
Among current smokers, longer duration of adult smoking and smoking more cigarettes per day were associated with increased odds of having reached natural menopause. Similar associations were observed with the menopausal transition (combined category), with current smokers smoking more than 10 cigarettes per day or those smoking for more than 26 years having a higher odds of experiencing the menopausal transition ( Table 2 ). Former smoking was not associated with being in the menopausal transition or with having had natural menopause. Table 4 shows the results obtained when exposures throughout the life course were examined simultaneously. Compared with participants who had neither prenatal nor current adult smoke exposure, participants had higher adjusted odds of reaching natural menopause if they had (i) prenatal smoke exposure only (OR, 2.7), (ii) current smoke 
Smoke exposure throughout the life course
DISCUSSION
Our data suggest that prenatal smoke exposure and adult current smoking are each associated with a twofold or larger increase in the odds of earlier menopause. Although the magnitudes of the associations of each of the two types of smoke exposure with natural menopause were similar, neither was statistically significant. However, women who were exposed prenatally and were current active adult smokers experienced a more-than-threefold increased odds of early menopause. Our finding relating current smoking to the odds of reaching menopause, given age, is similar to those reported in the literature. 5, 10, 11, [33] [34] [35] Our finding for prenatal smoke exposure and the odds of menopause is similar to that reported by Strohsnitter et al 23 using data from the DESAD Project. In our study, neither prenatal nor current smoke exposure, when assessed in the same regression model, was associated with the menopausal transition.
Prenatal smoke exposure may influence the development of ovarian follicles, and subsequent exposures throughout the life course may either lead to follicle death or impair follicle development to the antral stage. Several chemicals in cigarette smoke can damage ovarian follicles, causing genetic damage 18 and oxidative stress. 16 There is also evidence that smoking affects the levels of several hormones, including FSH, 21,36-39 estradiol, 20, 40, 41 and prolactin, 19 although findings for estradiol have been inconsistent, showing both increases and decreases in levels among smokers. In a recent Danish study, 29 fetal ovaries from first-trimester induced abortions were examined. Prenatal exposure to smoke was associated with a decrease in the number of somatic cells in follicles and a nonsignificant decrease in the number of germ cells. 22 The survival of follicles requires somatic cells, and a reduction in the number of somatic cells might promote oocyte death across time. The three previous studies of prenatal smoke exposure and menopause or ovarian aging relied on report by the daughter or recall by the mother many years after the daughter was born. In the DESAD Project, researchers found an association 23 using data on prenatal smoke exposure obtained from the mothers 9 to 39 years after the birth of their daughters. In the Sister Study, a crosssectional study of more than 22,000 participants aged 35 to 59 years that obtained data on prenatal smoke exposure from the daughters, who were told to ask their mothers, researchers did not observe an association with the timing of menopause. 24 A third study that also classified maternal smoking based on report of the adult daughter reported no association between prenatal smoke exposure and a number of measures of ovarian aging. 21 Adult daughters' reports of their mother's smoking status before their own birth are probably less accurate than recalled data from the mothers themselves and may be one reason why no associations were detected in the two studies that obtained maternal smoking status from adult daughters. Because our data on prenatal smoke exposure were collected from the mothers during their pregnancy, misclassification is likely to be minimal.
We did not detect an association between household smoke exposure during childhood and menopause status. Even among participants with no prenatal exposure, no association was observed between household smoke in childhood and early natural menopause. However, because we collected data on household smoke in childhood from the adult interview, measurement error may have reduced our ability to detect an association. With respect to former active smoking exposure, our data are consistent with other studies suggesting that former smoking is unrelated to earlier age at menopause. 5, 10, 11 One possible explanation for the presence of associations with prenatal smoke exposure and current smoking, but not 
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with former smoking, is that biologic effects are limited to certain critical periods. Two such times might be (i) the prenatal period, when primordial follicles are formed, and (ii) near the end of a woman's reproductive life span, when the number of follicles approaches the critical threshold needed to maintain ovulation and menstruation. Similar to the findings reported by Strohsnitter et al 23 using data from the DESAD Project, we observed a stronger association between prenatal smoke exposure and timing of menopause among nonsmokers (OR ¼ 2.7) than among current smokers (OR ¼ 3.4/2.8 ¼ 1.2). It is possible that this finding may be a chance finding because, in our data, the ORs relating prenatal smoke exposure to menopause did not differ much between women who never smoked and women who were current smokers. Given the small number of menopause events (n ¼ 38) in our data, however, our ability to evaluate differences in the strength of association is limited. However, if this pattern of results reflects a true biologic phenomenon, one possibility is that the biologic effect of current smoking on follicle development (and on the hormone feedback loop) is strong enough to render the biologic effect of in utero smoke exposure undetectable.
Neither prenatal nor childhood smoke exposure was related to the occurrence of the menopausal transition (combined category). We observed an association between current smoking and the occurrence of the menopausal transition (combined category). Interpretation of these findings is hindered by (1) the lack of a standardized operational definition for the menopausal transition and (2) uncertainty about whether the timing of the menopausal transition is linked to the number of ovarian follicles. One might expect the same biologic processes to influence both the timing of the menopausal transition and the timing of menopause. The primary definition of ''the menopausal transition'' used in this study (60 d of amenorrhea during the past year not attributable to pregnancy or lactation) is endorsed by researchers in the Stages of Reproductive Aging Workshop 31 and ReSTAGE Collaboration. 42 However, more recent research has shown that although this definition predicts the timing of the final menstrual period well in older women, other definitions may be better predictors of menopausal timing in women younger than 45 years. 43 More than half of the participants in this study were younger than 45 years. Hence, other definitions of ''the menopausal transition,'' such as more than one episode of 60-day amenorrhea, may be better indicators of late menopausal transition and may consequently capture associations that were not observed with the definition that we used. Information obtained from our questionnaire did not allow us to refine our definition of ''the menopausal transition.''
A key strength of this study is the collection of data on prenatal smoke exposure from the mothers of participants during their pregnancies. The data were also collected at a time when the health effects of smoking during pregnancy were less widely known and hence women were less likely to provide inaccurate information on their smoking habits during pregnancy for fear of stigmatization. A limitation of our study is the relatively young age of the sample and the fact that only 38 women had experienced natural menopause. Nevertheless, we were still able to address the question of risk factors for very early onset of menopause and early menopausal transition. Following cohorts like ours though midlife and beyond to ascertain the risks associated with prenatal smoke exposure is essential, as retrospective assessments of prenatal smoke exposure may be subject to greater misclassification.
CONCLUSIONS
Our study confirms the association between current smoking and earlier age at menopause and adds to the sparse literature on the relationship of prenatal smoke to the timing of menopause. Women who are exposed to smoke prenatally and throughout adulthood show a threefold increase in early natural menopause. Our findings support the growing literature indicating that various aspects of adult health and aging are influenced by exposures throughout the life course, including prenatal exposure, and should be replicated in larger prospective birth cohorts. 26, 44, 45 
